drugset / Trial / NCT07348172

Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings

NCT07348172

Phase 0 Not yet recruiting 100 enrolled Stanford University
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.

Timeline

Start
2026-03-01
Primary completion
2027-03-31
Completion
2028-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule Intravenous

Indications

No indication recorded.